×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TRAW – traws pharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TRAW
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
07:18 am
traw
Traws Pharma (NASDAQ:TRAW) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $8.00 price target on the stock.
Medium
Report
Traws Pharma (NASDAQ:TRAW) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $8.00 price target on the stock.
12/3
07:02 am
traw
Traws Pharma (NASDAQ:TRAW) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Medium
Report
Traws Pharma (NASDAQ:TRAW) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
12/2
03:46 pm
traw
Traws Pharma (NASDAQ:TRAW) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Traws Pharma (NASDAQ:TRAW) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
11/13
07:40 am
traw
Traws Pharma GAAP EPS of -$0.34 [Seeking Alpha]
High
Report
Traws Pharma GAAP EPS of -$0.34 [Seeking Alpha]
11/13
07:00 am
traw
Traws Pharma Reports Third Quarter 2025 Results and Business Highlights
High
Report
Traws Pharma Reports Third Quarter 2025 Results and Business Highlights
10/30
12:31 pm
traw
Traws Pharma (NASDAQ:TRAW) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Traws Pharma (NASDAQ:TRAW) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
10/30
12:00 pm
traw
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials
Medium
Report
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials
10/22
06:40 pm
traw
Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-Free Antiviral for COVID-19.
High
Report
Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-Free Antiviral for COVID-19.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/28
04:31 pm
traw
Form 8-K Traws Pharma, Inc. For: Nov 21
Medium
Report
Form 8-K Traws Pharma, Inc. For: Nov 21
11/25
06:53 pm
traw
Form 4 Traws Pharma, Inc. For: Nov 21 Filed by: Leaman John Harold
Low
Report
Form 4 Traws Pharma, Inc. For: Nov 21 Filed by: Leaman John Harold
11/14
04:00 pm
traw
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: PERCEPTIVE ADVISORS LLC
Medium
Report
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: PERCEPTIVE ADVISORS LLC
11/14
02:29 pm
traw
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: Squadron Capital Management LLC
Medium
Report
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: Squadron Capital Management LLC
11/13
09:07 am
traw
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: Adage Capital Management, L.P.
High
Report
Form SCHEDULE 13G/A Traws Pharma, Inc. Filed by: Adage Capital Management, L.P.
11/13
07:31 am
traw
Form 10-Q Traws Pharma, Inc. For: Sep 30
High
Report
Form 10-Q Traws Pharma, Inc. For: Sep 30
11/13
07:01 am
traw
Form 8-K Traws Pharma, Inc. For: Nov 13
High
Report
Form 8-K Traws Pharma, Inc. For: Nov 13
10/17
05:04 pm
traw
Form 8-K Traws Pharma, Inc. For: Oct 12
High
Report
Form 8-K Traws Pharma, Inc. For: Oct 12
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: